NOMO-1人急性單核細(xì)胞白血返回列表頁

舉報評價

參考價

面議

具體成交價以合同協(xié)議為準(zhǔn)

產(chǎn)品型號

品牌

廠商性質(zhì)生產(chǎn)商

所在地

在線詢價加入對比查看聯(lián)系電話

更新時間：2025-02-11 17:38:00瀏覽次數(shù)：19次

聯(lián)系我時，請告知來自化工儀器網(wǎng)

同類優(yōu)質(zhì)產(chǎn)品更多>

Rat podocyte大鼠腎

參考價面議
McA-RH7777大鼠肝癌細(xì)

參考價面議
SDBMSCSD大鼠骨髓間充質(zhì)

參考價面議
DSL-6A/C1 大鼠胰腺癌

參考價面議
Walker256-TC大鼠乳

參考價面議

產(chǎn)品分類品牌分類

細(xì)胞庫 / 細(xì)胞培養(yǎng): 細(xì)胞株 ATCC細(xì)胞原代細(xì)胞干細(xì)胞普通細(xì)胞

全部產(chǎn)品列表

產(chǎn)品簡介

NOMO-1人急性單核細(xì)胞白血病細(xì)胞CatalogueNo

詳情介紹

NOMO-1 人急性單核細(xì)胞白血病細(xì)胞
Catalogue No.: C948
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

Item	Specifications
a 15 ml centrifuge tube	2X10⁶
Manual	1 copy

characteristics. Given the role of the innate immune system in tumorigenesis and development, an improved understanding of the anti-tumor process of innate immune checkpoint inhibitors can lay the foundation for more effective combinations with other anti-tumor treatment strategies.Background: The ebdgcacy of cancer immunotherapy can be limited by the poor immunogenicity of cancer and the immunosuppressive tumor